COVID-19-associated phlebopathy – myth or reality?
https://doi.org/10.21518/akh2022-001
About the Author
K. V. Lobastov
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Kirill V. Lobastov, Cand. Sci. (Med.), Associate Professor of the Department of General Surgery of the Faculty of Medicine,
1, Ostrovityanov St., Moscow, 117997
References
1. Bogachev V.Yu., Boldin B.V., Turkin P.Yu., Dzhenina O.V. COVID-19-associated phlebopathy as a current problem of modern phlebology. Ambulatornaya Khirurgiya. 2022;19(2):13–20. (In Russ.) https://doi.org/10.21518/1995-1477-2022-19-2.
2. Lobastov K.V., Schastlivtsev I.V., Porembskaya O.Y., Dzenina O.V., Bargandzhiya A.B., Tsaplin S.N. COVID-19-associated coagulopathy: review of current recommendations for diagnosis, treatment and prevention. Ambulatornaya Khirurgiya. 2020;(3-4):36–51. (In Russ.) https://doi.org/10.21518/1995-1477-2020-3-4-36-51.
3. Lobastov K.V., Porembskay O.Y., Schastlivtsev I.V. The effectiveness and safety of the use of antithrombotic therapy in COVID-19. Ambulatornaya Khirurgiya. 2021;18(2):17–30. (In Russ.) https://doi.org/10.21518/1995-1477-2021-18-2.
4. Stepanov E., Lobastov K., Tsaplin S., Schastlivtsev I., Bargandzhiya A., Laberko L., Rodoman G. Efficacy and safety of increased doses of anticoagulants in COVID-19 patients: A systematic review and meta-analysis. Vasc Invest Ther. 2022;5(3):59–67. Available at: https://www.vitonline.org/text.asp?2022/5/3/59/360870.
5. Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11(2):269. https://doi.org/10.3390/pathogens11020269.
6. Zolotukhin I.A., Kirienko A.I. Functional venous insufficiency (phlebopathy) of the lower extremities: clinic, diagnosis, treatment. Flebologiya. 2009;3(3):3–9. (In Russ.) Available at: https://elibrary.ru/item.asp?id=15235416.
7. Peiris S., Mesa H., Aysola A., Manivel J., Toledo J., Borges-Sa M. et al. Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS ONE. 2021;16(4):e0250708. https://doi.org/10.1371/journal.pone.0250708.
8. Perrin M., Eklof B., van Rij A., Labropoulos N., Vasquez M., Nicolaides A. et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35(4):374–398. Available at: https://pubmed.ncbi.nlm.nih.gov/27081866/.
9. Lattimer C.R., Kalodiki E., Geroulakos G., Hoppensteadt D., Fareed J. Are Inflammatory Biomarkers Increased in Varicose Vein Blood? Clin Appl Thromb Hemost. 2016;22(7):656–664. https://doi.org/10.1177/1076029616645330.
10. Turner B.R.H., Machin M., Jasionowska S., Salim S., Onida S., Shalhoub J., Davies A.H. Systematic Review and meta-analysis of the Additional Benefit of Pharmacological Thromboprophylaxis for Endovenous Varicose Vein Interventions. Ann Surg. 2022. https://doi.org/10.1097/SLA.0000000000005709.
11. Lattimer C.R., Fareed J., Hoppensteadt D., Maia P., Ligi D., Mannello F., Kalodiki E. Validation of a Gravitational Model to Study Local Endogenous Biomarkers in Chronic Venous Insufficiency. Eur J Vasc Endovasc Surg. 2018;56(6):865–873. https://doi.org/10.1016/j.ejvs.2018.08.004.
12. Kakkos S.K., Nicolaides A.N. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality oflife in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebocontrolled trials. Int Angiol. 2018;37(2):143–154. https://doi.org/10.23736/S0392-9590.18.03975-5.
Review
For citations:
Lobastov K.V. COVID-19-associated phlebopathy – myth or reality? Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2023;20(1):198-200. (In Russ.) https://doi.org/10.21518/akh2022-001
Views:
498
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 